Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Intervention with Radiation in Recurrent Glioma
NCT02149459Phase 1Unknown
- Sponsor
- Sheba Medical Center
- Start
- Jun 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of metformin in glioma, sponsored by Sheba Medical Center. Primary endpoints: Number of patients with adverse events at 8 weeks and Number of patients completing the trial at 8 weeks. Status: unknown.
02
Drugs
metformin
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02149459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149459.